{{Rsnum
|rsid=2838815
|Gene=ADARB1
|Chromosome=21
|position=45209675
|Orientation=plus
|GMAF=0.4839
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ADARB1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 26.8 | 40.2 | 33.0
| HCB | 24.1 | 55.5 | 20.4
| JPT | 24.8 | 46.9 | 28.3
| YRI | 32.0 | 47.6 | 20.4
| ASW | 26.3 | 49.1 | 24.6
| CHB | 24.1 | 55.5 | 20.4
| CHD | 32.1 | 45.9 | 22.0
| GIH | 21.8 | 44.6 | 33.7
| LWK | 35.5 | 45.5 | 19.1
| MEX | 39.7 | 43.1 | 17.2
| MKK | 24.4 | 48.1 | 27.6
| TSI | 10.8 | 59.8 | 29.4
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs2838815
|PubMedID=17903307
|Condition=Other pulmonary function traits
|Gene=ADARB1
|Risk Allele=
|pValue=3.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs2838815
|Name_s=
|Gene_s=ADARB1
|Feature=
|Evidence=PubMed ID:17903307; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Framingham Heart Study genome-wide association: results for pulmonary function measures (Initial Sample Size: 1,097-1,222 individuals, depending on measure (Framingham); Replication Sample Size: NR). This variant is associated with pulmonary function traits.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356437
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2838815
|overall_frequency_n=68
|overall_frequency_d=128
|overall_frequency=0.53125
|n_genomes=39
|n_genomes_annotated=0
|n_haplomes=58
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}